Open AccessAnalysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital
Author(s) -
Joseph M. Herman,
Michael J. Swartz,
Charles C. Hsu,
Jordan M. Winter,
Timothy M. Pawlik,
Elizabeth A. Sugar,
Ray Robinson,
Daniel A. Laheru,
Elizabeth M. Jaffee,
Ralph H. Hruban,
Kurtis A. Campbell,
Christopher L. Wolfgang,
F. Asrari,
Ross C. Donehower,
Manuel Hidalgo,
Luis A. Díaz,
Charles J. Yeo,
John L. Cameron,
Richard D. Schulick,
Ross A. Abrams
Publication year - 2008
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2007.15.8469
Subject(s) - medicine , interquartile range , pancreaticoduodenectomy , chemoradiotherapy , fluorouracil , surgery , radiation therapy , adenocarcinoma , resection margin , prospective cohort study , cohort , pancreatectomy , gastroenterology , chemotherapy , cancer , pancreas , resection
To examine the efficacy of adjuvant chemoradiotherapy after pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma (PC) in patients undergoing resection at Johns Hopkins Hospital (JHH; Baltimore, MD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom